🇺🇸 FDA
Patent

US 8221768

Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

granted A61KA61K2039/53A61K2039/70

Quick answer

US patent 8221768 (Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K48/00